chr1-17587608-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018125.4(ARHGEF10L):c.186C>A(p.Asp62Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000341 in 1,613,772 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018125.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ARHGEF10L | NM_018125.4 | c.186C>A | p.Asp62Glu | missense_variant | 3/29 | ENST00000361221.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ARHGEF10L | ENST00000361221.8 | c.186C>A | p.Asp62Glu | missense_variant | 3/29 | 1 | NM_018125.4 | A1 | |
ARHGEF10L | ENST00000375415.5 | c.186C>A | p.Asp62Glu | missense_variant | 2/27 | 1 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152156Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000718 AC: 18AN: 250648Hom.: 0 AF XY: 0.000103 AC XY: 14AN XY: 135432
GnomAD4 exome AF: 0.0000363 AC: 53AN: 1461498Hom.: 0 Cov.: 30 AF XY: 0.0000371 AC XY: 27AN XY: 727046
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152274Hom.: 0 Cov.: 33 AF XY: 0.0000269 AC XY: 2AN XY: 74450
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | The c.186C>A (p.D62E) alteration is located in exon 3 (coding exon 2) of the ARHGEF10L gene. This alteration results from a C to A substitution at nucleotide position 186, causing the aspartic acid (D) at amino acid position 62 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at